In a significant move to tackle the ongoing issue of high prescription drug prices in the U.S., President Donald Trump has signed an executive order aimed at reducing costs for American consumers. The executive order, signed on May 12, 2025, introduces a set of bold new policies designed to overhaul the way the U.S. pharmaceutical…